ABP501 is equivalent to originator adalimumab

ABP501 is similar to originator adalimumab in clinical efficacy, safety, and immunogenicity INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It can also affect internal organs. Rheumatoid arthritis is more common in older people, but there is also a high prevalence in young adults, adolescents and […]

Read More…

Moderate alcohol consumption may not affect liver blood tests in people taking methotrexate

Weekly alcohol consumption of less than 14 units per week does not appear to be associated with an increased risk of abnormal liver blood tests. Introduction Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It can also affect internal organs. Rheumatoid arthritis is more common in older […]

Read More…

Sticking to a healthy diet over many years may protect against rheumatoid arthritis

Women with a healthy diet may be less likely to develop rheumatoid arthritis Introduction Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It can also affect internal organs. Rheumatoid arthritis is more common in older people, but there is also a high prevalence in young adults, adolescents […]

Read More…

Short-term changes on MRI predict long-term changes on X-ray

Short-term changes on MRI predict long-term changes on X-ray MRI is a valid method for monitoring joint damage in short-duration randomised clinical trials. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. Although many treatments that stop inflammation and joint destruction have been introduced over the past […]

Read More…

Filgotinib is effective in people with insufficient response to methotrexate

Filgotinib improved signs and symptoms of rheumatoid arthritis over 24 weeks and was associated with fast onset of action. INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. Filgotinib belongs to a new group of medicines called targeted synthetic disease modifying antirheumatic drugs (sometimes also called tsDMARDs). […]

Read More…

Patient and doctor disagreement may reduce likelihood of remission

Differences between patient and physician evaluation of disease activity and pain may impact individual treat-to-target strategy INTRODUCTION Rheumatoid arthritis and psoriatic arthritis are two types of rheumatic disease. Both are chronic inflammatory diseases that affect a person’s joints, causing pain and disability. Rheumatoid arthritis can affect men and women of all ages. The inflammation can […]

Read More…

MRI may be a valid biomarker in RA

MRI measures of inflammation and structural damage correlate independently with physical function, pain and patient global assessments INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It is more common in older people, and affects both men and women. The use of patient-reported outcomes (often shortened to […]

Read More…

Seronegative patients have higher disease activity

The 2010 ACR/EULAR classification criteria for rheumatoid arthritis may not be appropriate for people withseronegative disease INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It can also affect internal organs. It is more common in older people, but there is also a high prevalence in youngadults, […]

Read More…

RA-BUILD shows clinical improvement with baricitinib

Baricitinib gives clinical improvement and inhibits joint damage in people with rheumatoid arthritis and an inadequate response or intolerance to csDMARDs INTRODUCTION Rheumatoid arthritis is a chronic inflammatory disease that affects a person’s joints, causing pain and disability. It is more common in older people, and affects both men and women. Baricitinib is a new […]

Read More…